Wells Fargo & Company Moderna, Inc. Put Options Transaction History

Wells Fargo & Company

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2023 May 12, 2023	BUY	$135.66 - $197.02 $6.78 Million - $9.85 Million	50,000 Added 50000.0%	50,100 $7.69 Million
Q4 2022 Feb 13, 2023	BUY	$118.38 - $210.04 $11,838 - $21,004	100 New	100 $17,000
Q2 2022 Aug 12, 2022	BUY	$117.13 - $176.59 $1.16 Million - $1.75 Million	9,900 Added 9900.0%	10,000 $1.43 Million
Q1 2022 May 16, 2022	SELL	$126.46 - $235.05 $3.01 Million - $5.59 Million	-23,800 Reduced 99.58%	100 $17,000
Q4 2020 Feb 09, 2021	BUY	$65.74 - $169.86 $1.57 Million - $4.06 Million	23,900 New	23,900 $1.2 Million

953

240M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.